ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

HIV/AIDS

  WHO > Programmes and projects > HIV/AIDS > Topics > Injecting drug use and prisons

Injecting drug use and prisons

IDU needles

Globally, around 16 million people inject drugs and 3 million of them are living with HIV. Explosive HIV epidemics occur in populations of injecting drug users (IDUs) where re-use and sharing of injecting equipment are common.

On average, one out of every ten new HIV infections is caused by injecting drug use and in some countries and regions, this percentage is much higher: over 80 per cent of all HIV infections in Eastern Europe and Central Asia is related to drug use.

WHO strongly supports harm reduction as an evidence-based approach to HIV prevention, treatment and care for drug users. WHO advocates for Universal access to a comprehensive harm reduction package of interventions for drug injectors which includes needle and syringe programmes, drug dependence treatment - in particular opioid substitution therapy - as well as risk reduction counselling, HIV testing and counselling, and HIV treatment and care.

WHO works closely with UNODC, UNAIDS and other stakeholders including civil society to advocate for the implementation of these interventions.

Latest Updates

1 February 2010 - Dispatch from Lithuania
WHO supported Knowledge Hubs represent progress in the expansion of harm reduction services.
Article | Photo essay HTML | Flash | Interview

Interventions to reduce HIV transmission related to injecting drug use in prison
The Lancet - Volume 9, Issue 1, 2009. The high prevalence of HIV infection and drug dependence among prisoners, combined with the sharing of injecting drug equipment, make prisons a high-risk environment for the transmission of HIV.
Read the article [pdf 128kb]

IDU cd
New CD with key IDU documents
A CD titled 'HIV prevention, treatment and care for injecting drug users and prisoners' has been produced. This contains all documents developed by WHO related to harm reduction and can be ordered by an email to hividu@who.int


Policy and programming
Policy and programming
More information

Needle and syringe programmes
Needle and syringe programmes
More information

Opioid substitution therapy and drug dependence
Opioid substitution therapy and drug dependence
More information

HIV care and antiretroviral therapy
More information

Outreach
Outreach
More information

Sexual transmission
More information

Prisons
More information

IDU Links
Links to harm reduction networks
More information

IDU links
Other useful sites
More information


TOP HIGHLIGHTS

IDU target setting Thumbnail
Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users
More information

WHO controlled medicines database
For more information on producers, formulations and prices of methadone and buprenorphine please visit the new WHO controlled medicines database.
More information

Evidence for action series - technical papers and policy briefs
More information


CONTACT IDU

HIV/AIDS Programme
World Health Organization
20, Avenue Appia
1211 Geneva, 27 Switzerland
Email: hividu@who.int